|
Volumn 2, Issue 9, 1996, Pages 29-56
|
Outing HIV (or, the tailor retailored).
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INTERLEUKIN 10;
INTERLEUKIN 2;
PROTEINASE INHIBITOR;
VIRUS RNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
AFRICA;
ANTIBIOTIC RESISTANCE;
BLOOD;
CD4 LYMPHOCYTE COUNT;
CHILD;
CHINA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG COMBINATION;
DRUG EFFECT;
EUROPE;
FEMALE;
GENETICS;
HEMOPHILIA A;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
IMMUNOTHERAPY;
INFANT;
ISOLATION AND PURIFICATION;
MALE;
PRACTICE GUIDELINE;
TREATMENT OUTCOME;
UNITED STATES;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
AFRICA;
AIDS VACCINES;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
CHILD;
CHINA;
CLINICAL TRIALS;
DRUG RESISTANCE, MICROBIAL;
DRUG THERAPY, COMBINATION;
EUROPE;
FEMALE;
HEMOPHILIA A;
HIV;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV SEROPREVALENCE;
HUMANS;
IMMUNOTHERAPY;
INFANT;
INTERLEUKIN-10;
INTERLEUKIN-2;
MALE;
PRACTICE GUIDELINES;
RNA, VIRAL;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 0030236808
PISSN: 1081454X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|